Bilateral chemosis and conjunctival venous engorgement in cardiopulmonary failure.
D000368:Aged; D001249:Asthma / Q000150:complications; D001991:Bronchitis / Q000150:complications; D002245:Carbon Dioxide / Q000097:blood; D006328:Cardiac Catheterization; D003228:Conjunctiva / Q000098:blood supply*; D004039:Diet, Sodium-Restricted; D004077:Digoxin / Q000627:therapeutic use; D004487:Edema / Q000209:etiology*; D005128:Eye Diseases / Q000209:etiology; D005260:Female; D005665:Furosemide / Q000627:therapeutic use; D006333:Heart Failure / Q000150:complications* / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D006940:Hyperemia / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D010102:Oxygen Inhalation Therapy; D011189:Potassium Chloride / Q000627:therapeutic use; D011656:Pulmonary Emphysema / Q000150:complications; D011658:Pulmonary Fibrosis / Q000150:complications; D011660:Pulmonary Heart Disease / Q000150:complications; D012131:Respiratory Insufficiency / Q000150:complications* / Q000188:drug therapy / Q000209:etiology; D014680:Veins
D002245:Carbon Dioxide; D011189:Potassium Chloride; D004077:Digoxin; D005665:Furosemide; D010100:Oxygen